These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 30907413)

  • 1. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry.
    Mahfoud F; Böhm M; Schmieder R; Narkiewicz K; Ewen S; Ruilope L; Schlaich M; Williams B; Fahy M; Mancia G
    Eur Heart J; 2019 Nov; 40(42):3474-3482. PubMed ID: 30907413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years.
    Ott C; Mahfoud F; Mancia G; Narkiewicz K; Ruilope LM; Fahy M; Schlaich MP; Böhm M; Schmieder RE
    Nephrol Dial Transplant; 2022 Jan; 37(2):304-310. PubMed ID: 34109413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Renal Denervation for Patients with Uncontrolled Hypertension in Taiwan: 3-Year Results From the Global SYMPLICITY Registry-Taiwan (GSR-Taiwan).
    Lee CK; Wang TD; Lee YH; Fahy M; Lee CH; Sung SH; Kao HL; Wu YW; Lin TH
    Acta Cardiol Sin; 2019 Nov; 35(6):618-626. PubMed ID: 31879514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry.
    Linz D; Mancia G; Mahfoud F; Narkiewicz K; Ruilope L; Schlaich M; Kindermann I; Schmieder RE; Ewen S; Williams B; Böhm M;
    J Hypertens; 2017 Jan; 35(1):148-153. PubMed ID: 27906840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry.
    Böhm M; Ukena C; Ewen S; Linz D; Zivanovic I; Hoppe U; Narkiewicz K; Ruilope L; Schlaich M; Negoita M; Schmieder R; Williams B; Zeymer U; Zirlik A; Mancia G; Mahfoud F;
    J Hypertens; 2016 Dec; 34(12):2480-2486. PubMed ID: 27755390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
    Mahfoud F; Bakris G; Bhatt DL; Esler M; Ewen S; Fahy M; Kandzari D; Kario K; Mancia G; Weber M; Böhm M
    Eur Heart J; 2017 Jan; 38(2):93-100. PubMed ID: 28158510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
    Tsioufis C; Ziakas A; Dimitriadis K; Davlouros P; Marketou M; Kasiakogias A; Thomopoulos C; Petroglou D; Tsiachris D; Doumas M; Skalidis E; Karvounis C; Alexopoulos D; Vardas P; Kallikazaros I; Stefanadis C; Papademetriou V; Tousoulis D
    Clin Res Cardiol; 2017 May; 106(5):322-330. PubMed ID: 27957627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renal denervation on kidney function in patients with chronic kidney disease.
    Hering D; Marusic P; Duval J; Sata Y; Head GA; Denton KM; Burrows S; Walton AS; Esler MD; Schlaich MP
    Int J Cardiol; 2017 Apr; 232():93-97. PubMed ID: 28089459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation.
    Völz S; Spaak J; Elf J; Jägrén C; Lundin C; Stenborg A; Andersson J; Rundqvist B; Kahan T; Andersson B
    J Hypertens; 2018 Jan; 36(1):151-158. PubMed ID: 29210862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
    Böhm M; Mahfoud F; Ukena C; Hoppe UC; Narkiewicz K; Negoita M; Ruilope L; Schlaich MP; Schmieder RE; Whitbourn R; Williams B; Zeymer U; Zirlik A; Mancia G;
    Hypertension; 2015 Apr; 65(4):766-74. PubMed ID: 25691618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
    Böhm M; Mahfoud F; Townsend RR; Kandzari DE; Pocock S; Ukena C; Weber MA; Hoshide S; Patel M; Tyson CC; Weil J; Agdirlioglu T; Fahy M; Kario K
    Eur Heart J; 2019 Mar; 40(9):743-751. PubMed ID: 30608521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension.
    Sesa-Ashton G; Nolde JM; Muente I; Carnagarin R; Lee R; Macefield VG; Dawood T; Sata Y; Lambert EA; Lambert GW; Walton A; Kiuchi MG; Esler MD; Schlaich MP
    Hypertension; 2023 Apr; 80(4):811-819. PubMed ID: 36762561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    Wang L; Li C; Li Z; Li Q; Liu C; Sun X; He Q; Xia DS; Xia D; Lu C
    J Hypertens; 2024 May; 42(5):801-808. PubMed ID: 38164953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients - .
    Kario K; Ogawa H; Okumura K; Okura T; Saito S; Ueno T; Haskin R; Negoita M; Shimada K;
    Circ J; 2015; 79(6):1222-9. PubMed ID: 25912693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
    Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
    J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension.
    Liu S; Bian R; Qian Y; Liao H; Gao X; Zhang Y; Dong W
    J Clin Hypertens (Greenwich); 2023 Jan; 25(1):71-77. PubMed ID: 36478498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan　- Safety and Efficacy of Renal Denervation at 3 Years.
    Kario K; Yamamoto E; Tomita H; Okura T; Saito S; Ueno T; Yasuhara D; Shimada K;
    Circ J; 2019 Feb; 83(3):622-629. PubMed ID: 30760655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
    Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.